Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Neuroblastoma 1 Lymphoma, Large B-Cell, Diffuse 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Cancer Pain 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

Cyclophosphamide 28 Temozolomide 25 Irinotecan 21 dinutuximab 20 Topotecan 15 Magnetic Resonance Spectroscopy 13 Specimen Handling 12 Biopsy 12 naxitamab 11 Granulocyte-Macrophage Colony-Stimulating Factor 11 3-Iodobenzylguanidine 11 Vincristine 10 Etoposide 10 sargramostim 9 Melphalan 9 Isotretinoin 9 fludarabine 8 X-Rays 8 Colony-Stimulating Factors 8 Carboplatin 8 etoposide phosphate 7 Phantoms, Imaging 7 Doxorubicin 7 fludarabine phosphate 6 Stem Cell Transplantation 6 Nuclear Medicine Department, Hospital 6 Eflornithine 6 Thiotepa 5 Granulocyte Colony-Stimulating Factor 5 Filgrastim 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroblastoma × Antibodies × 1 year × Clear all

NCT02914405 2026-04-28

MiniVan

University Hospital Southampton NHS Foundation Trust

Phase 1 Active not recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡